We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $5.49B
1-Year Est. Return 46.89%
This Fund
S&P 500
This Quarter Est. Return
+30.41%
1 Year Est. Return
+46.89%
3 Year Est. Return
+94.27%
5 Year Est. Return
+129.04%
10 Year Est. Return
+529.98%
AUM
$5.49B
AUM Growth
+$1.51B
Cap. Flow
+$309M
Cap. Flow %
5.62%
Top 10 Hldgs %
60.68%
Holding
58
New
14
Increased
15
Reduced
15
Closed
13

Top Buys

Rank Stock Value
1
A icon
Agilent Technologies
A
+$240M
2
TMO icon
Thermo Fisher Scientific
TMO
+$181M
3
DHR icon
Danaher
DHR
+$180M
4
GPN icon
Global Payments
GPN
+$175M
5
META icon
Meta Platforms (Facebook)
META
+$143M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$301M
2
AMD icon
Advanced Micro Devices
AMD
+$144M
3
DXC icon
DXC Technology
DXC
+$112M
4
GTM
ZoomInfo Technologies
GTM
+$95.1M
5
CNC icon
Centene
CNC
+$71M

Sector Composition

Rank Sector Weight
1 Healthcare 49.86%
2 Industrials 12.99%
3 Technology 12.58%
4 Consumer Discretionary 9.03%
5 Miscellaneous 8.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GPN icon
1
Global Payments
GPN
$24.3B
$646M 11.77%
8,906,709
+2,546,317
+40% +$175M
CVS icon
2
CVS Health
CVS
$119B
$499M 9.09%
4,824,799
-3,372,000
-41% -$301M
THC icon
3
Tenet Healthcare
THC
$21.5B
$418M 7.62%
2,235,666
+710,812
+47% +$131M
TMO icon
4
Thermo Fisher Scientific
TMO
$230B
$314M 5.73%
627,240
+376,715
+150% +$181M
AMZN icon
5
Amazon
AMZN
$2.87T
$303M 5.52%
1,271,687
+212,417
+20% +$53.3M
IWM icon
6
PUT
iShares Russell 2000 ETF
IWM
$80.8B
$276M 5.02%
918,200
+543,200
+145% +$153M
A icon
7
Agilent Technologies
A
$43.4B
$262M 4.76%
+1,969,541
New +$240M
DHR icon
8
Danaher
DHR
$152B
$218M 3.97%
1,145,979
+989,704
+633% +$180M
META icon
9
Meta Platforms (Facebook)
META
$1.47T
$201M 3.66%
356,841
+234,179
+191% +$143M
SPY icon
10
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$825B
$194M 3.54%
+260,000
New +$189M
AMD icon
11
Advanced Micro Devices
AMD
$760B
$173M 3.16%
298,410
-352,382
-54% -$144M
TEVA icon
12
Teva Pharmaceuticals
TEVA
$42.5B
$172M 3.13%
5,081,091
-1,579,129
-24% -$52.6M
VTRS icon
13
Viatris
VTRS
$18.8B
$157M 2.86%
9,877,409
+790,165
+9% +$12.2M
UBER icon
14
Uber
UBER
$161B
$129M 2.36%
1,793,598
+337,726
+23% +$24.8M
CNC icon
15
Centene
CNC
$32B
$121M 2.2%
1,886,055
-1,327,591
-41% -$71M
BFLY icon
16
Butterfly Network
BFLY
$2.24B
$121M 2.2%
14,335,055
– –
CI icon
17
Cigna
CI
$73.7B
$114M 2.07%
412,223
-86,618
-17% -$24.5M
HUM icon
18
Humana
HUM
$46.3B
$101M 1.84%
254,216
-80,676
-24% -$23M
XYZ
19
Block Inc
XYZ
$50.2B
$91M 1.66%
1,197,046
-167,425
-12% -$11.8M
DKS icon
20
Dick's Sporting Goods
DKS
$12.1B
$91M 1.66%
401,067
+102,156
+34% +$22.6M
GENI icon
21
Genius Sports
GENI
$2.15B
$81.8M 1.49%
13,495,287
+4,934,399
+58% +$25.5M
ONTO icon
22
Onto Innovation
ONTO
$16.6B
$77.9M 1.42%
205,791
-93,930
-31% -$26.6M
LLY icon
23
Eli Lilly
LLY
$1.05T
$69.3M 1.26%
+57,771
New +$59M
UAL icon
24
United Airlines
UAL
$35.9B
$67.3M 1.23%
494,736
-2,124
-0.4% -$220K
EYE icon
25
National Vision
EYE
$1.37B
$59M 1.07%
3,101,083
+1,535,166
+98% +$31.3M
1
2 3

Similar funds

GCM
Graham Capital Management Rowayton, Connecticut $5.5B AUM 26.66% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $5.49B AUM 56.94% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MC
Maplelane Capital New York $5.51B AUM 67.92% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
NC
Nicholas Company Milwaukee, Wisconsin $5.47B AUM 16.96% 1-Year Est. Return
EI
EFG International Zurich $5.46B AUM
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return

Glenview Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Glenview Capital Management held 58 positions worth $5.49B, up 38% from $3.98B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Glenview Capital Management deployed $309M of net new capital in Q2 2026, opening 14 new positions and adding to 15 existing holdings. Its largest new stake was Agilent Technologies: 1,969,541 shares worth $262M.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, up from 45% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was CVS Health, an estimated $301M trimmed.

  • Glenview Capital Management's largest Q2 2026 buy was Agilent Technologies: 1,969,541 shares worth $262M.
  • Glenview Capital Management added most to Thermo Fisher Scientific in Q2 2026, an estimated $181M increase.
  • Glenview Capital Management's biggest Q2 2026 reduction was CVS Health, cutting an estimated $301M.
  • Glenview Capital Management fully exited DXC Technology in Q2 2026, selling an estimated $112M.
  • Glenview Capital Management's ten largest holdings make up 61% of its $5.49B portfolio in Q2 2026.
  • Glenview Capital Management opened 14 new positions and closed 13 in Q2 2026.
  • Glenview Capital Management's portfolio value rose 38% quarter-over-quarter to $5.49B.

Based on Glenview Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.